Pay in 4 interest-free payments of $6.65 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Triple agonist (GLP-1 / GIP / GCG) under investigation in metabolic research
Each requires different reconstitution volumes and produces different concentrations
When an amylin analogue like cagrilintide is paired with a GLP-1/GIP receptor agonist, the complementary mechanisms appear to produce additive appetite suppression: cagrilintide slows gastric emptying through amylin receptor activation, while tirzepatide simultaneously boosts insulin secretion and reduces glucagon
Ongoing check ins to adjust your plan as needed
A smaller group reports success with injecting just before bed
US$ 22.93
US$ 27.86
US$ 28.71
US$ 24.99
US$ 28.82
US$ 25.59
US$ 28.62
US$ 20.73
US$ 24.09
US$ 21.89
